Advertisement

Topics

Biomoda Company Profile

06:09 EST 11th December 2018 | BioPortfolio

Biomoda, Inc. is a developmental stage company engaged in the business of developing biopharmaceutical technology to diagnose and treat human diseases. The Company currently licenses two patents in the U.S. On November 10, 1992, the Company licensed a patent for the detection of cancers of the lung. A second patent, dealing with treatment of cancers of the lung, was licensed on February 21, 1995. A third patent, which deals with detecting pre-cancerous conditions in human tissue, is currently pending. Biomoda, Inc., is a biopharmaceutical company focusing on very early cancer detection technology. Biomoda’s novel cell-targeting technology is globally patented for the detection of pre-cancerous and cancerous conditions in all human tissue. This technology, originally called Tetrakis Carboxy Phenyl Porphine (TCPP), was developed at Los Alamos National Laboratories. Biomoda obtained a worldwide exclusive license to the TCPP technology from the University of California in late 1995, and began new research broadening the scope of the original patent and technology. In November 2000, Biomoda filed a new U.S. provisional patent application defining the ability of Biomoda’s version of the TCPP to detect pre-cancerous and cancerous conditions in all human tissue.

Location

8301 Washington St. NE, Suite 6
Albuquerque
87113
United States of America

Contact

Phone: 505.821.0875
Fax: 505-858-1871


News Articles [0 Results]

None

Drugs and Medications [0 Results]

None

PubMed Articles [0 Results]

None

Clinical Trials [1 Associated Clinical Trials listed on BioPortfolio]

Sputum Labeling Utilizing Synthetic Meso Tetra (4-Carboxyphenyl) Porphine (TCPP) for Detection of Lung Cancer

Primary Objective: - To determine the clinical sensitivity and specificity of the Biomoda CyPath™ Early Lung Cancer Detection Assay using sputum specimens from two cohorts of pa...

Companies [2 Associated Companies listed on BioPortfolio]

Biomoda, Inc.

Biomoda (www.biomoda.com) is a cancer diagnostics company focused on the development of accurate, inexpensive and noninvasive tests for the early detection of cancer. In ad...

Biomoda

Biomoda, Inc. is a developmental stage company engaged in the business of developing biopharmaceutical technology to diagnose and treat human diseases. The Company currently licenses two patents in th...

More Information about "Biomoda" on BioPortfolio

We have published hundreds of Biomoda news stories on BioPortfolio along with dozens of Biomoda Clinical Trials and PubMed Articles about Biomoda for you to read. In addition to the medical data, news and clinical trials, BioPortfolio also has a large collection of Biomoda Companies in our database. You can also find out about relevant Biomoda Drugs and Medications on this site too.

Advertisement
Quick Search
Advertisement
Advertisement

 

Relevant Topics

Biopharmaceuticals
Biopharmaceuticals are medical drugs produced using biotechnology. They include proteins (including antibodies), nucleic acids (DNA, RNA or antisense oligonucleotides) and living microorganisms like virus and bacteria where the virulance of viruses and b...

Pulmonary
Pulmonary relating to or associated with the lungs eg Asthma, chronic bronchitis, emphysema, COPD, Cystic Fibrosis, Influenza,  Lung Cancer, Pneumonia, Pulmonary Arterial Hypertension, Sleep Disorders etc Follow and track Lung Cancer News ...


Corporate Database Quicklinks



Searches Linking to this Company Record